Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently submitted to: JMIR Research Protocols

Date Submitted: Jan 23, 2026
Open Peer Review Period: Jan 26, 2026 - Mar 23, 2026
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).

Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Identifying metabolic pathways that drive gestational diabetes in pregnancy: Protocol for a prospective observational study

  • Felix Jebasingh; 
  • Lakshmi Marri Harika; 
  • Shajith Anoop; 
  • Mandisa Christian; 
  • Sherin Daniel; 
  • Santhosh Joseph Benjamin; 
  • Swati Rathore; 
  • Reeta Vijaya Selvi; 
  • Manisha Madhai Beck; 
  • Anuja Abraham; 
  • RN Preethi; 
  • Ullas Kolthur Seetharam; 
  • Mahendra Sonawane; 
  • Sarah Price; 
  • Elif Ilhan Ekinci; 
  • Nihal Thomas

ABSTRACT

Background:

Gestational Diabetes is a disorder characterised by hyperglycaemia that is first recognised during pregnancy due to a mismatch between the placental hormones produced, causing insulin resistance. Few studies have systematically examined the metabolic pathways responsible for gestational diabetes from diagnosis to the postnatal period, including the metabolic changes in the placenta through metabolomics studies.

Objective:

This study aimed to evaluate the metabolites identified through metabolomics, as well as their associated pathways, responsible for hyperglycaemia in the gestational period across pregnancy and postpartum, compared to those without diabetes during pregnancy. Serum samples are taken at 24-28 weeks of gestation, followed by placental samples, cord blood, and postnatal serum samples between 4 and 12 weeks.

Methods:

Anthropometric data is collected at the first visit. Samples are collected at three points: serum or plasma samples at the time of diagnosis of gestational diabetes or the first visit after diagnosis, placental samples and cord blood samples during delivery, and during the postpartum period. Macroscopic and microscopic features of the placenta are noted. The metabolic pathways between GDM and non-GDM mothers across pregnancy, starting from the diagnosis of gestational diabetes, and the changes in pathways in the placenta, cord blood, and postnatal blood will be compared.

Results:

The study was funded by an institutionally funded research grant in January 2025. Recruitment for the study began in June 2025 and is expected to be completed by June 2026. We plan to recruit 40 patients with GDM and age- and BMI-matched normoglycaemic controls.

Conclusions:

The findings from this study will provide insight into the various metabolites or biomarkers and their metabolic pathways involved in the pathogenesis of gestational diabetes across the life course of mothers, compared with those of normoglycemic mothers, and offer potential insight into the role of the placenta in gestational diabetes.


 Citation

Please cite as:

Jebasingh F, Harika LM, Anoop S, Christian M, Daniel S, Benjamin SJ, Rathore S, Selvi RV, Beck MM, Abraham A, Preethi R, Seetharam UK, Sonawane M, Price S, Ilhan Ekinci E, Thomas N

Identifying metabolic pathways that drive gestational diabetes in pregnancy: Protocol for a prospective observational study

JMIR Preprints. 23/01/2026:92064

DOI: 10.2196/preprints.92064

URL: https://preprints.jmir.org/preprint/92064

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.